Lista de obras - Zahi Touma - Dominio Público Uruguay

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

artículo científico publicado en 2019

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

scientific article published on 05 August 2019

A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index.

artículo científico publicado en 2018

Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients ⬇️

artículo científico publicado el 24 de noviembre de 2011

Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans

scientific article published on 14 May 2018

Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus

artículo científico publicado en 2019

Associations among classification criteria items within systemic lupus erythematosus

artículo científico publicado en 2019

Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study

artículo científico publicado en 2017

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus

artículo científico publicado en 2018

Cardiac sarcoidosis responding to monotherapy with infliximab

artículo científico publicado en 2007

Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus

artículo científico publicado en 2019

Clinical and Demographic Characteristics of Erosion-free and Erosion-present Status in Psoriatic Arthritis in a Cohort Study

artículo científico publicado en 2016

Cognitive function trajectories are associated with the depressive symptoms trajectories in systemic lupus erythematosus over time

artículo científico publicado en 2020

Comparison of Spot Urine Protein to Creatinine Ratio to 24-Hour Proteinuria to Identify Important Change Over Time in Proteinuria in Lupus.

artículo científico publicado en 2017

Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.

artículo científico publicado en 2017

Development and Initial Validation of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50 ⬇️

artículo científico publicado el 1 de diciembre de 2010

Development and assessment of users' satisfaction with the systemic lupus erythematosus disease activity index 2000 responder index-50 website.

artículo científico publicado en 2012

Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease.

artículo científico publicado en 2013

Disease course patterns in systemic lupus erythematosus

artículo científico publicado en 2018

Drs. Tayer-Shifman and Touma reply

artículo científico publicado en 2019

Dual trajectories of fatigue and disease activity in an inception cohort of adults with systemic lupus erythematosus over 10 years

artículo científico publicado en 2021

Effect of complete or partial proteinuria recovery on long-term outcomes of lupus nephritis.

artículo científico publicado en 2017

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

artículo científico publicado en 2018

Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome

scientific article published on 15 July 2018

Exploring the Mental Health Needs of Persons With Autoimmune Diseases During the Coronavirus Disease 2019 Pandemic: A Proposed Framework for Future Research and Clinical Care

artículo científico publicado en 2020

Family history of lymphoma and risk for solid tumors in patients with Sjogren’s syndrome

artículo científico publicado en 2007

Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept

artículo científico publicado en 2005

GRAPPA Trainees Symposium 2012: a report from the GRAPPA 2012 annual meeting.

artículo científico publicado en 2013

How Do Patients with Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria

artículo científico publicado en 2018

Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms.

artículo científico publicado en 2018

Identifying a response for the systemic lupus erythematosus disease activity glucocorticoid index (SLEDAI-2KG)

scientific article published on 20 May 2020

Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies

article

Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosus.

artículo científico publicado en 2016

Long-delayed onset of chest wall pain defining a patient with SAPHO syndrome.

artículo científico publicado en 2007

Longitudinal myelitis in patient with systemic lupus erythematosus, homozygous prothrombin G20210A and heterozygous MTHFR 677T

artículo científico publicado en 2007

Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review

artículo científico publicado en 2020

Measures of Anxiety in Rheumatic Diseases

artículo científico publicado en 2020

Measures of Cognition in Rheumatic Diseases

artículo científico publicado en 2020

Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus

artículo científico publicado en 2018

Minimal Clinically Important Difference: A Review of Outcome Measure Score Interpretation

artículo científico publicado en 2018

Monophasic Disease Course in Systemic Lupus Erythematosus

artículo científico publicado en 2018

Novel biological therapeutic approaches to cutaneous lupus erythematosus

scientific article published on 05 September 2018

Optimal Frequency of Visits for Patients with Systemic Lupus Erythematosus to Measure Disease Activity Over Time ⬇️

artículo científico publicado el 15 de noviembre de 2010

Oral bisphosphonates in treatment of transient osteoporosis

artículo científico publicado en 2007

Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.

artículo científico publicado en 2017

Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

artículo científico publicado en 2020

Predictors of Good Long-Term Renal Outcomes in Lupus Nephritis: Results from a Single Lupus Cohort

artículo científico publicado en 2017

Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis Magnetic Resonance Imaging Score (OMERACT JAMRIS-SIJ)

artículo científico publicado en 2019

Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus.

artículo científico publicado en 2016

Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease.

artículo científico publicado en 2017

Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis

scientific article published on 28 June 2019

Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus.

artículo científico publicado en 2014

Psoriatic Arthritis Sonographic Enthesitis Instruments: A Systematic Review of the Literature

artículo científico publicado en 2018

Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.

artículo científico publicado en 2016

Reply

Response of deep cutaneous vasculitis to infliximab

artículo científico publicado en 2005

Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies.

artículo científico publicado en 2016

SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation ⬇️

artículo científico publicado el 1 de enero de 2011

SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement

artículo científico publicado en 2015

SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 years ⬇️

artículo científico publicado el 16 de julio de 2012

Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes.

artículo científico publicado en 2011

Subcutaneous belimumab in the treatment of systemic lupus erythematosus

artículo científico publicado en 2018

Successful retreatment with infliximab in patients with prior severe infusion reactions.

artículo científico publicado en 2005

Successful treatment of Sjogren's syndrome with rituximab

scientific article published on 01 July 2006

Successful treatment of cardiac involvement in dermatomyositis with rituximab.

artículo científico publicado en 2007

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 Website ⬇️

artículo científico publicado el 1 de mayo de 2013

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials

scientific article published on 01 September 2011

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50: A Reliable Index for Measuring Improvement in Disease Activity ⬇️

artículo científico publicado el 15 de febrero de 2011

Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months

artículo científico publicado en 2012

Systemic lupus erythematosus symptom clusters and their association with patient-reported outcomes and treatment: Analysis of real-world data

scientific article published on 20 December 2020

Systemic lupus erythematosus: an update on current pharmacotherapy and future directions ⬇️

artículo científico publicado el 23 de enero de 2013

TNF polymorphisms in patients with Behçet disease: a meta-analysis.

scientific article published on February 2010

The Assessment of Anxiety and Depression and its Associated Factors in SLE

scientific article published on 01 January 2019

The assessment of disease activity in rheumatic diseases

artículo científico publicado en 2013

The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: Systematic literature review and analysis of the Toronto lupus cohort.

artículo científico publicado en 2016

Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment

artículo científico publicado en 2014

Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus.

artículo científico publicado en 2013

Utility of Urinary Protein-Creatinine Ratio and Protein Content in a 24-Hour Urine Collection in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.

artículo científico

Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus.

artículo científico publicado en 2015

Validity evidence supports the use of automated neuropsychological assessment metrics as a screening tool for cognitive impairment in lupus

scientific article published on 18 October 2019

What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis

artículo científico publicado en 2018

Lista de obras de Zahi Touma

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index.

Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients ⬇️

Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans

Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus

Associations among classification criteria items within systemic lupus erythematosus

Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus

Cardiac sarcoidosis responding to monotherapy with infliximab

Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus

Clinical and Demographic Characteristics of Erosion-free and Erosion-present Status in Psoriatic Arthritis in a Cohort Study

Cognitive function trajectories are associated with the depressive symptoms trajectories in systemic lupus erythematosus over time

Comparison of Spot Urine Protein to Creatinine Ratio to 24-Hour Proteinuria to Identify Important Change Over Time in Proteinuria in Lupus.

Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.

Development and Initial Validation of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50 ⬇️

Development and assessment of users' satisfaction with the systemic lupus erythematosus disease activity index 2000 responder index-50 website.

Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease.

Disease course patterns in systemic lupus erythematosus

Drs. Tayer-Shifman and Touma reply

Dual trajectories of fatigue and disease activity in an inception cohort of adults with systemic lupus erythematosus over 10 years

Effect of complete or partial proteinuria recovery on long-term outcomes of lupus nephritis.

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome

Exploring the Mental Health Needs of Persons With Autoimmune Diseases During the Coronavirus Disease 2019 Pandemic: A Proposed Framework for Future Research and Clinical Care

Family history of lymphoma and risk for solid tumors in patients with Sjogren’s syndrome

Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept

GRAPPA Trainees Symposium 2012: a report from the GRAPPA 2012 annual meeting.

How Do Patients with Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria

Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms.

Identifying a response for the systemic lupus erythematosus disease activity glucocorticoid index (SLEDAI-2KG)

Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies

Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosus.

Long-delayed onset of chest wall pain defining a patient with SAPHO syndrome.

Longitudinal myelitis in patient with systemic lupus erythematosus, homozygous prothrombin G20210A and heterozygous MTHFR 677T

Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review

Measures of Anxiety in Rheumatic Diseases

Measures of Cognition in Rheumatic Diseases

Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus

Minimal Clinically Important Difference: A Review of Outcome Measure Score Interpretation

Monophasic Disease Course in Systemic Lupus Erythematosus

Novel biological therapeutic approaches to cutaneous lupus erythematosus

Optimal Frequency of Visits for Patients with Systemic Lupus Erythematosus to Measure Disease Activity Over Time ⬇️

Oral bisphosphonates in treatment of transient osteoporosis

Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.

Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

Predictors of Good Long-Term Renal Outcomes in Lupus Nephritis: Results from a Single Lupus Cohort

Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis Magnetic Resonance Imaging Score (OMERACT JAMRIS-SIJ)

Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus.

Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease.

Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis

Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus.

Psoriatic Arthritis Sonographic Enthesitis Instruments: A Systematic Review of the Literature

Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.

Reply

Response of deep cutaneous vasculitis to infliximab

Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies.

SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation ⬇️

SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement

SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 years ⬇️

Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes.

Subcutaneous belimumab in the treatment of systemic lupus erythematosus

Successful retreatment with infliximab in patients with prior severe infusion reactions.

Successful treatment of Sjogren's syndrome with rituximab

Successful treatment of cardiac involvement in dermatomyositis with rituximab.

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 Website ⬇️

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50: A Reliable Index for Measuring Improvement in Disease Activity ⬇️

Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months

Systemic lupus erythematosus symptom clusters and their association with patient-reported outcomes and treatment: Analysis of real-world data

Systemic lupus erythematosus: an update on current pharmacotherapy and future directions ⬇️

TNF polymorphisms in patients with Behçet disease: a meta-analysis.

The Assessment of Anxiety and Depression and its Associated Factors in SLE

The assessment of disease activity in rheumatic diseases

The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: Systematic literature review and analysis of the Toronto lupus cohort.

Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment

Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus.

Utility of Urinary Protein-Creatinine Ratio and Protein Content in a 24-Hour Urine Collection in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.

Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus.